Suppr超能文献

多参数碘-间位碘代苄胍闪烁扫描术在帕金森病鉴别诊断中的价值

Value of multi-parameter I-MIBG scintigraphy in the differential diagnosis of Parkinson's disease.

作者信息

Xue Teng, Cui Ying, Kan Ying, Wang Guanyun, Yang Jigang

机构信息

Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, China.

Department of Neurology, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, China.

出版信息

EJNMMI Res. 2025 Jan 29;15(1):7. doi: 10.1186/s13550-025-01197-8.

Abstract

BACKGROUND

I-MIBG scintigraphy plays a significant role in diagnosing Parkinson's disease (PD), with most studies primarily targeting cardiac uptake and relying on traditional ratio-based parameters for assessment. However, due to variations in scanning conditions and image processing methodologies, the clinical utility of different parameters remains a subject of debate. This study aims to evaluate the diagnostic accuracy of multi-parameter I-3-Iodobenzylguanidine (MIBG) scintigraphy and to identify the most reliable metrics for distinguishing PD from Parkinson-plus syndromes.

RESULT

We recruited 56 PD patients and 44 non-PD controls, who underwent I-MIBG scintigraphy and clinical evaluation. MIBG uptake and washout rates (WR) for the heart, salivary glands, and thyroid were assessed, with semi-quantitative methods used to calculate heart-to-mediastinum (H/M) and gland-to-background (P/B, S/B, T/B) ratios. Diagnostic efficacy was evaluated using receiver operating characteristic (ROC) curves. The H/M ratio and cardiac WR parameters scintigraphy exhibited excellent diagnostic efficacy for PD and PPS. The 4 h H/M ratio showed superior diagnostic performance with an area under the ROC curve (AUC) of 0.980. Background and time decay correction improved cardiac WR diagnostic performance (AUC = 0.963). Although P/B, S/B, and T/B ratios showed no significant differences for differential diagnosis, the WR values of the parotid and thyroid glands exhibited moderate diagnostic efficacy with AUCs of 0.648 and 0.638, respectively.

CONCLUSION

The heart H/M ratio and cardiac WR in I-MIBG scintigraphy show high diagnostic efficacy for both diagnosing and differentiating PD. Including cardiac WR in routine assessments is recommended. The diagnostic potential of WR in the parotid and thyroid glands also holds promise for PD diagnosis. Incorporating these parameters could enhance the accuracy of PD diagnosis, particularly in clinical scenarios where concurrent cardiac disease may confound the diagnosis.

摘要

背景

I-间碘苄胍(I-MIBG)闪烁扫描术在帕金森病(PD)的诊断中发挥着重要作用,大多数研究主要针对心脏摄取情况,并依赖基于传统比值的参数进行评估。然而,由于扫描条件和图像处理方法的差异,不同参数的临床效用仍存在争议。本研究旨在评估多参数I-3-碘苄胍(MIBG)闪烁扫描术的诊断准确性,并确定区分PD与帕金森叠加综合征最可靠的指标。

结果

我们招募了56例PD患者和44例非PD对照者,他们接受了I-MIBG闪烁扫描术和临床评估。评估了心脏、唾液腺和甲状腺的MIBG摄取和洗脱率(WR),采用半定量方法计算心脏与纵隔(H/M)以及腺体与本底(P/B、S/B、T/B)比值。使用受试者工作特征(ROC)曲线评估诊断效能。H/M比值和心脏WR参数闪烁扫描术对PD和帕金森叠加综合征(PPS)显示出优异的诊断效能。4小时H/M比值显示出卓越的诊断性能,ROC曲线下面积(AUC)为0.980。本底和时间衰减校正提高了心脏WR的诊断性能(AUC = 0.963)。虽然P/B、S/B和T/B比值在鉴别诊断中无显著差异,但腮腺和甲状腺的WR值显示出中等诊断效能,AUC分别为0.648和0.638。

结论

I-MIBG闪烁扫描术中的心脏H/M比值和心脏WR对PD的诊断和鉴别均显示出高诊断效能。建议在常规评估中纳入心脏WR。腮腺和甲状腺WR的诊断潜力对PD诊断也具有前景。纳入这些参数可提高PD诊断的准确性,特别是在并发心脏病可能混淆诊断的临床情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2111/11775374/f6df45a24aa6/13550_2025_1197_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验